The Valley Desk

Clinical trial reportCancer medicinePublished

Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Cancer medicine
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Antibodies, Bispecific; Adult; Aged; Middle Aged; Female; Male; Antineoplastic Agents, Immunological; Cytokine Release Syndrome; Clinical Management
PubMed ID
41036677
PubMed Central ID
PMC12489744
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal